4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0000882104-15-000012
CIK 0000882104operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:02 PM ET
Size
4.9 KB
Accession
0000882104-15-000012
Insider Transaction Report
Form 4
Hart Danny J Jr.
Assoc Genl Counsel/Asst Sec
Transactions
- Award
Common stock
2015-01-28$7.62/sh+28,543$217,498→ 77,920 total
Footnotes (1)
- [F1]The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2016; 16.66% on January 2017; 16.66% on January 2018; and 16.66% on January 2019.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:02 PM ET
- Size
- 4.9 KB